Antidepressive Agents

DBCAT000345Therapeutic categoryN06A

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. A DrugBank category of 326 drugs. 187 of them are approved.

ATC classification: N — NERVOUS SYSTEM
N06 — PSYCHOANALEPTICS
N06A — ANTIDEPRESSANTS
Part of: Central Nervous System Depressants
Also known as: Agents, Antidepressive · Antidepressant Drugs · Antidepressants · Drugs, Antidepressant · Thymoanaleptics
Drugs: 2,5-Dimethoxy-4-ethylthioamphetamine
4-Bromo-2,5-dimethoxyphenethylamine
5-methoxy-N,N-dimethyltryptamine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
Acepromazine
Adinazolam
Agomelatine
Alaproclate
Almotriptan
Alnespirone
Alosetron
Alprenolol
Altanserin
Alverine
Amesergide
Amibegron
Amiflamine
Amineptine
Amisulpride
Amitriptyline
Amitriptylinoxide
Amoxapine
Amperozide
Aniracetam
Apomorphine
and 301 more with a free account

What you can answer from here — as of August 12, 2019

326DrugsEach linked to its full drug card

244Drug targetsEvery drug–target pair in the class, with bond type

61,687Marketed productsAcross the regions we cover, with dosage forms and routes

37Routes of administrationHow the drugs in this class are given

7SubcategoriesNarrower classes within this one

Which targets do Antidepressive Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account